osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), and developmental dysplasia of the hip.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.18-80 years old; 2. Body mass index (BMI) is 20-35 kg/m2; 3. Functional status of American Society of Anesthesiologists (ASA) I-III; 4) Primary unilateral total hip replacement..
Exclusion criteria
Exclusion criteria: 1. Hip joint stiffness; 2. Known allergy to the drugs used in this study; 3. History of opioid overdose; 4. Have a history of excessive drinking; 5. Cognitive impairment; 6. Mental illness; 7. Recognized neuromuscular diseases; 8. Previous history of open hip surgery; 9. The target hip suffers from other neurological diseases; 10. Unable to communicate orally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cumulative morphine consumption within 24 h after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative VAS score at rest.;Postoperative VAS score on movement.;Intraoperative consumption of opioids.;Times of sleep interruption due to pain on the night of surgery.;Postoperative quadriceps strength.;Time until the first walkout of bed after surgery.;Time to hospital discharge.;QoR-15 scale.;cumulative morphine consumption during hospitalization;Adverse effects associated with analgesias such as postoperative dizziness, nausea, vomiting, wound swelling, wound ooze, drowsiness, urinary retention, and falls after surgery were recorded.; | — |
Countries
China
Contacts
West China Hospital, Sichuan University